Massive study tracks 3,450 patients with aortic stenosis to uncover prognosis clues
NCT ID NCT03628313
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 3,450 patients with aortic valve narrowing (aortic stenosis) to better understand their long-term outlook. Researchers will look at ultrasound measurements and other factors to find what predicts how the disease progresses. The goal is to improve how doctors assess risk and make treatment decisions, but no new drug or procedure is being tested.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 3,450 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2015
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The participants will be identified from the transthoracic echocardiography reports of the echocardiography laboratory of CHU Amiens and CH Saint Philibert for the retrospective part. They are prospectively identified during echocardiography performed in the echocardiography laboratory of the two participating centers when a diagnosis of aortic stenosis is made. Patients will be informed by newsletter.
- Ages
-
18 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Retrospectively, all patients examined from January 1, 2000 to November 2014 will be included in the echocardiography laboratory whose objective examination is a narrowing of the aortic valve (maximum transaortic velocity ≥2.5 m / s). * Aortic stenosis may be known in the past. Exclusion Criteria: * Refusal of the patient to participate in the study. * Patients who have previously had aortic valve surgery before being examined in the echocardiography laboratory. * Patients who can not be contacted or who do not respond will not be included in the database.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Morality are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Chu Amiens-Picardie
RECRUITINGAmiens, France, 80000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Global study aims to uncover why lifesaving oxygen often fails to reach patients
- Smart ventilator settings may cut Post-Surgery lung failure
- Heart transplant patients get hepatitis c cure hope
- ICU delirium drug study pulled before starting
- Anemia duration may predict ventilator days in ICU patients
- Tiny study compares trazodone and quetiapine for ICU delirium – but was cut short